These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5529716)

  • 41. Purification and functional characterization of bothrojaractivase, a prothrombin-activating metalloproteinase isolated from Bothrops jararaca snake venom.
    Berger M; Pinto AF; Guimarães JA
    Toxicon; 2008 Mar; 51(4):488-501. PubMed ID: 18262582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 44. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen).
    Maurer MC; Trumbo TA; Isetti G; Turner BT
    Arch Biochem Biophys; 2006 Jan; 445(1):36-45. PubMed ID: 16364233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: investigation of A alpha-chain N-terminal heterogeneity.
    Southan C; Thompson E; Lane DA
    Thromb Haemost; 1986 Oct; 56(2):193-7. PubMed ID: 3643663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Release of human and horse fibrinopeptides.
    Teger-Nilsson AC
    Acta Chem Scand; 1967; 21(7):1879-86. PubMed ID: 5586735
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release.
    Gralnick HR; Givelber HM; Shainoff JR; Finlayson JS
    J Clin Invest; 1971 Sep; 50(9):1819-30. PubMed ID: 5564389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for localization of polymerization sites in fibrinogen.
    Kudryk BJ; Collen D; Woods KR; Blombäck B
    J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342
    [No Abstract]   [Full Text] [Related]  

  • 50. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin.
    Merskey C; Johnson AJ; Lalezari P
    J Clin Invest; 1972 Apr; 51(4):903-11. PubMed ID: 5014617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolation and characterization of the thrombin-like enzyme from Cryptelytrops purpureomaculatus venom.
    Tan NH
    Comp Biochem Physiol C Toxicol Pharmacol; 2010 Jan; 151(1):131-6. PubMed ID: 19770070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Retention of thrombin by polytetrafluoroethylene: influence on the adsorption of fibrinogen/fibrin.
    Schlosser E; Simler R; Hörmann H
    Biomaterials; 1993 Apr; 14(5):365-70. PubMed ID: 8507780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of endothelial cell differential attachment to fibrin and fibrinogen and its inhibition by Arg-Gly-Asp-containing peptides.
    Chang MC; Wang BR; Huang TF
    Thromb Haemost; 1995 Aug; 74(2):764-9. PubMed ID: 8585019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin.
    McKee PA; Mattock P; Hill RL
    Proc Natl Acad Sci U S A; 1970 Jul; 66(3):738-44. PubMed ID: 5269236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of Arvin on reticuloendothelial activity in rabbits.
    Ashford A; Bunn DR
    Br J Pharmacol; 1970 Sep; 40(1):37-44. PubMed ID: 5487022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maintenance dose of Arvin.
    Reid HA
    Lancet; 1969 May; 1(7604):1048-9. PubMed ID: 4181271
    [No Abstract]   [Full Text] [Related]  

  • 58. Platelet and plasma fibrinogens are identical gene products.
    Doolittle RF; Takagi T; Cottrell BA
    Science; 1974 Jul; 185(4148):368-70. PubMed ID: 4834369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Separation of the coagulant components of Bothrops jararaca venom.
    Denson KW; Rousseau WE
    Toxicon; 1970 May; 8(1):15-9. PubMed ID: 5465746
    [No Abstract]   [Full Text] [Related]  

  • 60. Molecular weight of human fibrinogen derived from phosphorus determinations.
    Fantl P; Ward HA
    Biochem J; 1965 Sep; 96(3):886-9. PubMed ID: 5862426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.